172 related articles for article (PubMed ID: 37400677)
21. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
22. Filamin A is required in injured axons for HDAC5 activity and axon regeneration.
Cho Y; Park D; Cavalli V
J Biol Chem; 2015 Sep; 290(37):22759-70. PubMed ID: 26157139
[TBL] [Abstract][Full Text] [Related]
23. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase 5 promotes Wilms' tumor cell proliferation through the upregulation of c-Met.
Cao X; Liu DH; Zhou Y; Yan XM; Yuan LQ; Pan J; Fu MC; Zhang T; Wang J
Mol Med Rep; 2016 Mar; 13(3):2745-50. PubMed ID: 26847592
[TBL] [Abstract][Full Text] [Related]
25. Functional relevance of SATB1 in immune regulation and tumorigenesis.
Sunkara KP; Gupta G; Hansbro PM; Dua K; Bebawy M
Biomed Pharmacother; 2018 Aug; 104():87-93. PubMed ID: 29772444
[TBL] [Abstract][Full Text] [Related]
26. HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer.
Xue Y; Lian W; Zhi J; Yang W; Li Q; Guo X; Gao J; Qu H; Lin W; Li Z; Lai L; Wang Q
Br J Cancer; 2019 Dec; 121(12):1039-1049. PubMed ID: 31690832
[TBL] [Abstract][Full Text] [Related]
27. Approaches for Studying the Subcellular Localization, Interactions, and Regulation of Histone Deacetylase 5 (HDAC5).
Guise AJ; Cristea IM
Methods Mol Biol; 2016; 1436():47-84. PubMed ID: 27246208
[TBL] [Abstract][Full Text] [Related]
28. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
29. HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition.
Jaguva Vasudevan AA; Hoffmann MJ; Beck MLC; Poschmann G; Petzsch P; Wiek C; Stühler K; Köhrer K; Schulz WA; Niegisch G
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052182
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase 5 (HDAC5) regulates neuropathic pain through SRY-related HMG-box 10 (SOX10)-dependent mechanism in mice.
Gu P; Pan Z; Wang XM; Sun L; Tai LW; Cheung CW
Pain; 2018 Mar; 159(3):526-539. PubMed ID: 29447134
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase regulates beta-catenin transcription via histone deacetylase 5.
Zhao JX; Yue WF; Zhu MJ; Du M
J Biol Chem; 2011 May; 286(18):16426-34. PubMed ID: 21454484
[TBL] [Abstract][Full Text] [Related]
32. Involvement of Epac1/Rap1/CaMKI/HDAC5 signaling cascade in the regulation of placental cell fusion.
Chang CW; Cheong ML; Chang GD; Tsai MS; Chen H
Mol Hum Reprod; 2013 Nov; 19(11):745-55. PubMed ID: 23867755
[TBL] [Abstract][Full Text] [Related]
33. Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency.
Wang Y; Li W; Schulz VP; Zhao H; Qu X; Qi Q; Cheng Y; Guo X; Zhang S; Wei X; Liu D; Yazdanbakhsh K; Hillyer CD; Mohandas N; Chen L; Gallagher PG; An X
Blood; 2021 Oct; 138(17):1615-1627. PubMed ID: 34036344
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a non-canonical role of HDAC5 in regulation of the cardiac Ncx1 and Bnp genes.
Harris LG; Wang SH; Mani SK; Kasiganesan H; Chou CJ; Menick DR
Nucleic Acids Res; 2016 May; 44(8):3610-7. PubMed ID: 26704971
[TBL] [Abstract][Full Text] [Related]
35. HDAC5 promotes osteosarcoma progression by upregulation of Twist 1 expression.
Chen J; Xia J; Yu YL; Wang SQ; Wei YB; Chen FY; Huang GY; Shi JS
Tumour Biol; 2014 Feb; 35(2):1383-7. PubMed ID: 24092570
[TBL] [Abstract][Full Text] [Related]
36. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.
Lenoir O; Flosseau K; Ma FX; Blondeau B; Mai A; Bassel-Duby R; Ravassard P; Olson EN; Haumaitre C; Scharfmann R
Diabetes; 2011 Nov; 60(11):2861-71. PubMed ID: 21953612
[TBL] [Abstract][Full Text] [Related]
37. HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression.
Hu T; Schreiter FC; Bagchi RA; Tatman PD; Hannink M; McKinsey TA
J Biol Chem; 2019 May; 294(21):8640-8652. PubMed ID: 30962285
[TBL] [Abstract][Full Text] [Related]
38. Interferon-inducible T-cell alpha chemoattractant (ITAC) induces the melanocytic migration and hypopigmentation through destabilizing p53 via histone deacetylase 5: a possible role of ITAC in pigment-related disorders.
Lee E; Choi SY; Bin BH; Kim NH; Kim KH; Choi DH; Han J; Choi H; Lee AY; Lee TR; Cho EG
Br J Dermatol; 2017 Jan; 176(1):127-137. PubMed ID: 27436825
[TBL] [Abstract][Full Text] [Related]
39. Liganded peroxisome proliferator-activated receptors (PPARs) preserve nuclear histone deacetylase 5 levels in endothelin-treated Sprague-Dawley rat cardiac myocytes.
Zhang H; Shao Z; Alibin CP; Acosta C; Anderson HD
PLoS One; 2014; 9(12):e115258. PubMed ID: 25514029
[TBL] [Abstract][Full Text] [Related]
40. SMRT-mediated co-shuttling enables export of class IIa HDACs independent of their CaM kinase phosphorylation sites.
Soriano FX; Chawla S; Skehel P; Hardingham GE
J Neurochem; 2013 Jan; 124(1):26-35. PubMed ID: 23083128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]